Intel (INTC) plans to issue $15 billion in common stock. In essence, it’s a way to “top up” the funding for the AI-driven arms race—an example of the typical playbook of 📉 short-term pain and 📈 long-term gains.
Fueled by unprecedented investment in AI compute, growth opportunities have emerged across areas such as physical AI, specialized chips, advanced packaging, and outsourced wafer manufacturing. Intel will use the proceeds for capital expenditures and working capital to help it seize these growth opportunities. In its second quarter, Intel’s foundry operations incurred an operating loss of $2.089 billion. For 2026, its capital spending has been raised to more than $20 billion. Free cash flow was negative $8.419 billion—this is a “money-burning black hole” from heavy-asset investment that urgently needs equity infusions. After the news was released, INTC fell more than 5% intraday to $97.52, with a single-day 📉 decline of 4.06%.
In the peer landscape, TSM (TSM) remains atop the foundry throne at $418.47, up 38.56% year-to-date; AMD closed at $469.56, 📉 down 2.86%. Intel wants to steal some share from TSM with its 18A/14A process nodes and advanced packaging using EMIB. The challenge is significant, but the story is compelling—this is also the basis for its stock price surge of 164.28% this year.
Short term, the outlook is 📉: concerns about equity dilution from the new share issuance pressure the stock.
Long term, the outlook is 📈: if foundry orders truly materialize and 14A enters mass production in 2028 as planned, today’s dilution is essentially buying a ticket for long-term competitiveness.
Goldman Sachs maintains a Neutral rating and a target price of $150, implying roughly 42% upside. That figure aptly reflects that the market is still watching its strategy of “trading capital for time.” #英特尔将发行150亿美元普通股
$INTC
$TSM
$AMD
Fueled by unprecedented investment in AI compute, growth opportunities have emerged across areas such as physical AI, specialized chips, advanced packaging, and outsourced wafer manufacturing. Intel will use the proceeds for capital expenditures and working capital to help it seize these growth opportunities. In its second quarter, Intel’s foundry operations incurred an operating loss of $2.089 billion. For 2026, its capital spending has been raised to more than $20 billion. Free cash flow was negative $8.419 billion—this is a “money-burning black hole” from heavy-asset investment that urgently needs equity infusions. After the news was released, INTC fell more than 5% intraday to $97.52, with a single-day 📉 decline of 4.06%.
In the peer landscape, TSM (TSM) remains atop the foundry throne at $418.47, up 38.56% year-to-date; AMD closed at $469.56, 📉 down 2.86%. Intel wants to steal some share from TSM with its 18A/14A process nodes and advanced packaging using EMIB. The challenge is significant, but the story is compelling—this is also the basis for its stock price surge of 164.28% this year.
Short term, the outlook is 📉: concerns about equity dilution from the new share issuance pressure the stock.
Long term, the outlook is 📈: if foundry orders truly materialize and 14A enters mass production in 2028 as planned, today’s dilution is essentially buying a ticket for long-term competitiveness.
Goldman Sachs maintains a Neutral rating and a target price of $150, implying roughly 42% upside. That figure aptly reflects that the market is still watching its strategy of “trading capital for time.” #英特尔将发行150亿美元普通股
$INTC
$TSM
$AMD